Her research focuses on tiny blood vessels that are one-tenth the diameter of a human hair, needed to regenerate tissues damaged by...
We start with a focus on biology.
Whether we are modeling or engineering cells and tissues, analyzing large datasets, developing new imaging technologies, or synthesizing novel biomaterials, the problem statement always starts with the biology underlying the system, therapy, or disease process.
Our co-location within the highly-ranked UVA School of Medicine and UVA Health System uniquely positions us to influence the future of healthcare. Our culture values and rewards collaboration, initiative, and the translation of basic advances to achieve clinical and real world impact. In all that we do, we value and strive for diversity and inclusion.
Biomedical engineering post-doctoral fellow Dan Abebayehu plans to tackle fibrosis by identifying different types of fibroblasts and...
Kinase inhibitors are the most common cancer drugs approved by the FDA. They can be hugely effective, but they don’t work for everyone...
The Leducq Foundation, which is dedicated to battling cardiovascular disease and stroke, has funded four projects worldwide for 2022...
Lantheus Medical Imaging Distinguished Professor of Cardiovascular Medicine, Chief, Division of Cardiovascular Medicine
- Biotechnology and Biomolecular Engineering (Biomolecular Design, Cellular and Molecular Bioengineering)
- Computational Systems Biology
- Cardiovascular Engineering
Increase in total research expenditures since 2015
$ 14 M
FY21 External Research Expenditures ($602K per tenured or tenure track faculty member)
Federally funded student training programs, including two NIH T32 Training Grants and an NSF REU
Years in a row that a graduating biomedical engineer was a "UVA Engineering Outstanding Student."